-
Mashup Score: 5
ENRICH Trial met its primary endpoint demonstrating MIPS using BrainPath and Myriad improved functional outcomes versus medical management alone.
Source: NICO CorporationCategories: Latest Headlines, NeurologyTweet
ENRICH Trial met its primary endpoint demonstrating MIPS using BrainPath and Myriad improved functional outcomes versus medical management alone.
NICO announces world's first positive surgical trial for ICH! Topline data from the #ENRICHtrial demonstrate early minimally invasive surgery with BrainPath® is superior to standard of care in #ICH. Read more about these revolutionary results: https://t.co/6IQrtzZzfs #ad https://t.co/xrxSIlB0Xl